SWAV

ShockWave Medical, Inc. [SWAV] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SWAV Stock Summary

Top 10 Correlated ETFs

SWAV


Top 10 Correlated Stocks

SWAV


In the News

10:20 29 Mar 2024 SWAV

Shockwave Medical rallies as J&J mulls purchase

Shockwave Medical shares are trading more than 3% higher in Wednesday's session, having soared more than 10% since it was announced Johnson & Johnson (NYSE:JNJ) was considering buying it. The maker of medical devices to treat heart diseases was reported to be an acquisition target for the healthcare giant on Tuesday by the Wall Street Journal.

05:17 29 Mar 2024 SWAV

Shockwave Medical shares rise on report of acquisition talks with Johnson & Johnson

Shares of medical-device maker Shockwave Medical Inc. rose Tuesday following a report that Johnson & Johnson was in talks to acquire the company.

02:33 29 Mar 2024 SWAV

Johnson & Johnson considers deal to buy Shockwave Medical, WSJ reports

Johnson & Johnson is in talks to buy medical device maker Shockwave Medical , the Wall Street Journal reported on Tuesday.

10:51 29 Mar 2024 SWAV

Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024

We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.

12:26 29 Mar 2024 SWAV

Reasons to Add ShockWave Medical (SWAV) to Your Portfolio Now

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

01:01 29 Mar 2024 SWAV

What Makes Shockwave Medical (SWAV) a Strong Momentum Stock: Buy Now?

Does Shockwave Medical (SWAV) have what it takes to be a top stock pick for momentum investors? Let's find out.

11:20 29 Mar 2024 SWAV

General Motors, Celsius Lead Five Non-AI Stocks Near Buy Points

Turnaround play General Motors and hot energy drink maker Celsius Holdings lead this weekend's watchlist.

10:41 29 Mar 2024 SWAV

Shockwave Medical (SWAV) Q4 Earnings Beat, Revenues Rise Y/Y

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

09:55 29 Mar 2024 SWAV

Shockwave Medical, Inc. (SWAV) Q4 2023 Earnings Call Transcript

Shockwave Medical, Inc. (SWAV) Q4 2023 Earnings Call Transcript

06:21 29 Mar 2024 SWAV

Shockwave Medical (SWAV) Surpasses Q4 Earnings and Revenue Estimates

Shockwave Medical (SWAV) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $3.71 per share a year ago.

SWAV Financial details

Company Rating
Strong Buy
Market Cap
10.51B
Income
147.28M
Revenue
730.23M
Book val./share
18.11
Cash/share
26.82
Dividend
-
Dividend %
-
Employees
1.47K
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
30.63
Forward P/E
53.56
PEG
-9.17
P/S
11.16
P/B
12.42
P/C
12.12
P/FCF
52.29
Quick Ratio
12.99
Current Ratio
14.43
Debt / Equity
1.1
LT Debt / Equity
1.09
-
-
EPS (TTM)
4.01
EPS next Y
6.07
EPS next Q
1.26
EPS this Y
-33.39%
EPS next Y
51.31%
EPS next 5Y
134.96%
EPS last 5Y
NAN%
Revenue last 5Y
76.26%
Revenue Q/Q
9.12%
EPS Q/Q
26.32%
-
-
-
-
SMA20
14.89%
SMA50
40%
SMA100
43.33%
Inst Own
68.75%
Inst Trans
0.78%
ROA
17%
ROE
42%
ROC
0.11%
Gross Margin
87%
Oper. Margin
24%
Profit Margin
36%
Payout
-
Shs Outstand
37.4M
Shs Float
36.62M
-
-
-
-
Target Price
238.4
52W Range
157.0-315.95
52W High
+3.22%
52W Low
+107.09%
RSI
83
Rel Volume
1.26
Avg Volume
517.53K
Volume
652.17K
Perf Week
13.83%
Perf Month
37.58%
Perf Quarter
60%
Perf Half Y
67.31%
-
-
-
-
Beta
0.895
-
-
Volatility
18.63%, 21.15%
Prev Close
0.78%
Price
325.13
Change
0.04%

SWAV Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.82.056.7612.9319.89
Net income per share
-2.14-1.99-0.265.74.01
Operating cash flow per share
-2.01-2.160.433.115.34
Free cash flow per share
-2.17-2.510.072.444.51
Cash per share
8.176.135.738.0426.99
Book value per share
8.066.836.8913.518.22
Tangible book value per share
8.066.836.8913.514.61
Share holders equity per share
8.066.836.8913.518.22
Interest debt per share
0.990.791.381.6420.21
Market cap
1.05B3.42B6.26B7.79B6.99B
Enterprise value
933.57M3.4B6.22B7.69B7.44B
P/E ratio
-20.54-52.12-685.136.0647.49
Price to sales ratio
24.4650.5126.3915.99.58
POCF ratio
-21.82-48.1416.2766.1635.68
PFCF ratio
-20.22-41.42.41K84.1142.27
P/B Ratio
5.4515.1725.8815.2310.46
PTB ratio
5.4515.1725.8815.2310.46
EV to sales
21.7550.1426.2215.7110.18
Enterprise value over EBITDA
-18.86-52.77-803.3462.6942.17
EV to operating cash flow
-19.41-47.75413.4865.3437.93
EV to free cash flow
-17.98-41.12.39K83.0744.95
Earnings yield
-0.05-0.0200.030.02
Free cash flow yield
-0.05-0.0200.010.02
Debt to equity
0.120.110.20.121.1
Debt to assets
0.10.090.140.090.47
Net debt to EBITDA
2.350.45.43-0.782.51
Current ratio
9.039.635.547.2511.76
Interest coverage
-54.91-54.18-0.7965.8226.79
Income quality
0.941.08-1.650.551.33
Dividend Yield
00000
Payout ratio
0-0.0300.030.04
Sales general and administrative to revenue
0.330.350.150.120.13
Research and developement to revenue
0.770.540.210.170.2
Intangibles to total assets
00000.08
Capex to operating cash flow
0.080.16-0.83-0.21-0.16
Capex to revenue
-0.09-0.17-0.05-0.05-0.04
Capex to depreciation
-1.67-3.44-2.25-5.17-2.95
Stock based compensation to revenue
0.080.150.110.090.1
Graham number
19.6917.496.3541.6140.55
ROIC
-0.23-0.2500.370.1
Return on tangible assets
-0.22-0.24-0.030.330.1
Graham Net
7.015.444.186.886.33
Working capital
192.69M220.72M234.27M395.89M1.12B
Tangible asset value
192.65M225.65M241.83M511.32M536.25M
Net current asset value
177.41M199.91M182.05M324.49M327.37M
Invested capital
0.120.110.20.121.1
Average receivables
5.11M9.53M24.56M54.4M92.96M
Average payables
2.14M2.13M2.49M5.12M7.79M
Average inventory
8.6M20.97M36.42M59.05M91.35M
Days sales outstanding
62.7362.9457.6253.1957.26
Days payables outstanding
59.3525.4931.0137.7433.93
Days of inventory on hand
256.83519.2378.56421.81411.68
Receivables turnover
5.825.86.336.866.37
Payables turnover
6.1514.3211.779.6710.76
Inventory turnover
1.420.70.960.870.89
ROE
-0.27-0.29-0.040.420.22
Capex per share
-0.16-0.35-0.35-0.66-0.83

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.984.424.915.065.5
Net income per share
3.891.070.790.951.2
Operating cash flow per share
1.450.931.081.381.94
Free cash flow per share
1.140.730.851.21.72
Cash per share
8.4211.447.0524.9326.82
Book value per share
14.1315.6716.8316.3418.11
Tangible book value per share
14.1315.6713.1612.7114.52
Share holders equity per share
14.1315.6716.8316.3418.11
Interest debt per share
1.73.851.6320.8520
Market cap
7.44B7.9B10.46B7.33B7.04B
Enterprise value
7.34B7.76B10.38B7.59B7.48B
P/E ratio
13.250.4790.6452.3539.71
Price to sales ratio
51.6549.0458.0839.3834.67
POCF ratio
141.86232.57263.33144.6498.15
PFCF ratio
179.87295.01337.67166.08110.68
P/B Ratio
14.5513.8416.9612.1910.52
PTB ratio
14.5513.8416.9612.1910.52
EV to sales
50.9848.1657.6240.8236.85
Enterprise value over EBITDA
160.94187.49307.02159.55156.95
EV to operating cash flow
140.03228.41261.26149.91104.31
EV to free cash flow
177.55289.73335.01172.13117.64
Earnings yield
0.020000.01
Free cash flow yield
0.01000.010.01
Debt to equity
0.120.240.11.271.1
Debt to assets
0.090.180.080.520.47
Net debt to EBITDA
-2.11-3.42-2.445.619.28
Current ratio
7.254.165.6914.4311.76
Interest coverage
43.7862.639.9717.3915.11
Income quality
0.370.871.381.451.62
Dividend Yield
00.010.0100.02
Payout ratio
0.012.132.760.13.76
Sales general and administrative to revenue
0.120.120.170.120.12
Research and developement to revenue
0.160.170.20.210.21
Intangibles to total assets
000.170.090.08
Capex to operating cash flow
-0.21-0.21-0.22-0.13-0.11
Capex to revenue
-0.08-0.04-0.05-0.04-0.04
Capex to depreciation
-7.2-4.21-3.41-2.17-2.64
Stock based compensation to revenue
0.090.10.090.10.11
Graham number
35.1919.4617.2618.722.11
ROIC
0.220.050.040.020.02
Return on tangible assets
0.220.050.040.030.03
Graham Net
7.218.495.664.556.29
Working capital
395.89M448.83M376.14M1.05B1.12B
Tangible asset value
511.32M570.69M482.43M467.68M536.25M
Net current asset value
324.49M378.27M286.67M255.83M327.37M
Invested capital
0.120.240.11.271.1
Average receivables
67.8M77.84M90.44M97.69M106.69M
Average payables
5.1M8.89M11.96M9.87M7.87M
Average inventory
72.04M79.18M87.67M94.64M102.38M
Days sales outstanding
44.647.1148.2447.8150.79
Days payables outstanding
34.5647.2147.2925.2231.53
Days of inventory on hand
386.25355.69338.4356.8382.48
Receivables turnover
2.021.911.871.881.77
Payables turnover
2.61.911.93.572.85
Inventory turnover
0.230.250.270.250.24
ROE
0.280.070.050.060.07
Capex per share
-0.31-0.2-0.24-0.18-0.22

SWAV Frequently Asked Questions

What is ShockWave Medical, Inc. stock symbol ?

ShockWave Medical, Inc. is a US stock , located in Santa clara of Ca and trading under the symbol SWAV

Is ShockWave Medical, Inc. buy or a sell ?

11 stock analysts have 11 predictions with a medium analyst target price of $229.73. The lowest prediction is $175 and the highest is $338

What is SWAV stock prediction ?

What is ShockWave Medical, Inc. stock quote today ?

ShockWave Medical, Inc. stock price is $325.13 today.

Is ShockWave Medical, Inc. stock public?

Yes, ShockWave Medical, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap